Latest news
Rigel Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Tue, 04 Aug 2026 21:01:27 GMTRigel posts Q2 2026 revenue $78.7M, net income $17.3M; raises 2026 revenue outlook - TradingViewTradingView · Tue, 04 Aug 2026 20:13:01 GMTRigel Pharmaceuticals Q2 revenue rises on strong product demand - TradingViewTradingView · Tue, 04 Aug 2026 20:11:51 GMTRIGL: Q2 2026 saw record product sales, VEPPANU in-licensing, and raised full-year revenue guidance - TradingViewTradingView · Tue, 04 Aug 2026 20:10:27 GMTRigel Reports Second Quarter 2026 Financial Results - TradingViewTradingView · Tue, 04 Aug 2026 20:01:00 GMTRIGL: VEPPANU launch and robust sales growth drive a strong outlook and pipeline momentum - TradingViewTradingView · Tue, 04 Aug 2026 13:19:06 GMTRIGL Q2'26 Earnings: EPS estimate is 0.09 USD - TradingViewTradingView · Mon, 03 Aug 2026 11:01:07 GMTRigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results - TradingViewTradingView · Tue, 28 Jul 2026 12:05:00 GMT